Markets:

Overview

News

Currencies

International

Treasuries

Relmada Therapeutics, Inc. - Common Stock (NQ:RLMD)

4.270 -0.050 (-1.16%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Relmada Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 28, 2022

Via Benzinga

Relmada Therapeutics And 2 Other Penny Stocks Insiders Are Aggressively Buying ↗

December 13, 2022

The Dow Jones closed higher by over 500 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 12, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 09, 2022

Via Benzinga

Looking Into Relmada Therapeutics's Recent Short Interest ↗

December 09, 2022

Relmada Therapeutics's (NASDAQ:RLMD) short percent of float has fallen 8.99% since its last report. The company recently reported that it has 2.77 million shares sold short, which is 9.31% of all...

Via Benzinga

Relmada Shares Nosedive As Another Depression Trial Goes Up In Smoke ↗

December 08, 2022

Via Benzinga

Relmada Stock Tumbles To 52-Week Low On Failed Depression Trial ↗

October 13, 2022

Via Benzinga

S&P 500 Rises 0.5%; Ciena Posts Upbeat Q4 Results ↗

December 08, 2022

U.S. stocks traded higher toward the end of trading, with the NASDAQ gaining around 100 points on Thursday.

Via Benzinga

Why Express Shares Are Trading Higher By 39%? Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

December 08, 2022

Gainers My Size, Inc. (NASDAQ: MYSZ) shares jumped 88% to $0.2839. My Size announced a 1-for-25 reverse stock split.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 08, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

December 08, 2022

During Thursday's trading, 138 companies set new 52-week lows.

Via Benzinga

Nasdaq Gains 100 Points; Rent the Runway Shares Spike Higher ↗

December 08, 2022

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Thursday.

Via Benzinga

Dow Rises 150 Points; US Jobless Claims Increase To 230,000 ↗

December 08, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining over 150 points on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 08, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

December 02, 2022

On Friday, 72 companies hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

November 29, 2022

On Tuesday, 89 companies set new 52-week lows.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2022 ↗

October 14, 2022

Upgrades

Via Benzinga

121 Stocks That Hit Their 52-Week Low ↗

October 14, 2022

New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows.

Via Benzinga

Why Otonomy Shares Dipped By Around 54%; Here Are 67 Biggest Movers From Yesterday ↗

October 14, 2022

Gainers Nutex Health Inc. (NASDAQ: NUTX) jumped 72.4% to settle at $0.9551 on Thursday. Nutex Health recently provided a corporate update.

Via Benzinga

Dow Surges 950 Points; S&P 500 Rises 3% ↗

October 13, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones jumping around 950 points on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 13, 2022

Gainers

Via Benzinga

Stocks Stage Midday Comeback After Red-Hot CPI Data ↗

October 13, 2022

The market is brushing off this morning's CPI data.

Via Talk Markets

Why Is Axsome Therapeutics (AXSM) Stock Up Today? ↗

October 13, 2022

Sometimes, company shares can catch a bid when a rival gets bad news. That's happening with Axsome today as AXSM stock moves higher.

Via InvestorPlace

Gold Down 1.5%; Domino's Pizza Shares Spike Higher ↗

October 13, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 150 points on Thursday.

Via Benzinga

Why Are Tech Stocks Down Today? ↗

October 13, 2022

Tech stocks aren't doing so hot on Thursday as investors react to the latest data from the Consumer Price Index (CPI) report for September.

Via InvestorPlace

Why Laser Photonics Shares Are Trading Higher By Around 44%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

October 13, 2022

Gainers FedNat Holding Company (NASDAQ: FNHC) shares jumped 89% to $0.4242 after dipping 34% on Wednesday.

Via Benzinga

Progressive, Asana And Some Other Big Stocks Moving Lower On Thursday ↗

October 13, 2022

U.S. stocks traded lower, with the Dow Jones gaining more than 100 points on Thursday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Why Is Relmada (RLMD) Stock Down 78% Today? ↗

October 13, 2022

Relmada Therapeutics (RLMD) stock is plummeting on Thursday as investors react to results from a Phase 3 clinical trial.

Via InvestorPlace

Relmada Tanks After 'Paradoxical Results' Undermine Depression Drug; Axsome Surges ↗

October 13, 2022

The company noted "paradoxical results" where the placebo, at times, topped the drug.

Via Investor's Business Daily

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 13, 2022

Gainers Corbus Pharmaceuticals (NASDAQ:CRBP) shares rose 24.6% to $0.14 during Thursday's pre-market session. The market value of their outstanding shares is at $17.1 million.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Relmada Therapeutics, Inc. - Common Stock (NQ:RLMD)

All News about Relmada Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today